# FDA Inspection 1084076 - Roswell Park Cancer Institute Corporation. Div. of Pathology - March 01, 2019

Source: https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute-corporation-div-of-pathology/023d24b4-5c35-47a1-b6a0-583f1004f69f
Source feed: FDA_Inspections

> FDA Inspection 1084076 for Roswell Park Cancer Institute Corporation. Div. of Pathology on March 01, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1084076
- Company Name: Roswell Park Cancer Institute Corporation. Div. of Pathology
- Inspection Date: 2019-03-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1284298 - 2025-09-19](https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute-corporation-div-of-pathology/336927ef-3675-4733-910c-4e1e42a079ad)
- [FDA Inspection 1284298 - 2025-09-19](https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute-corporation-div-of-pathology/463c004e-ae39-4b65-95d7-7a9f92f60cc2)
- [FDA Inspection 1284298 - 2025-09-19](https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute-corporation-div-of-pathology/83e9c892-5030-46c5-af0f-53cf8a567c4f)
- [FDA Inspection 1200624 - 2023-03-13](https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute-corporation-div-of-pathology/acfe24f0-a550-470c-8072-99afe4b47ef8)
- [FDA Inspection 1200624 - 2023-03-13](https://www.keypedia.com/records/fda_inspections/roswell-park-cancer-institute-corporation-div-of-pathology/c3e00a26-73b3-4d91-8bef-9db46f7177cc)

Company: https://www.keypedia.com/companies/roswell-park-cancer-institute-corporation-div-of-pathology/6e9694cd-483d-4566-97d5-5b1f0c755980

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d